OBJECTIVE: The ATP-binding cassette transporter A1 (ABCA1) R230C variant is associated with low HDL cholesterol levels, obesity, and the metabolic syndrome in Mexican-Mestizos. Because a pivotal role for ABCA1 in pancreatic beta-cell function was recently observed in the mouse model, we assessed the association of this variant with type 2 diabetes in this population. RESEARCH DESIGN AND METHODS: The initial group included 446 unrelated Mexican individuals: 244 with type 2 diabetes aged 20-69 years (121 with onset </=45 years), and 202 nondiabetic control subjects aged >50 years. An independent study group included 242 type 2 diabetic case subjects and 225 control subjects with similar characteristics. RESULTS: R230C/C230C genotypes were significantly more frequent in type 2 diabetic individuals (24.6%) than in control subjects (11.4%) in the initial study group (OR 2.501; P = 0.001). After stratifying by age at diagnosis, the association was significant only in the early-onset group (age at diagnosis </=45 years) (OR 3.776, P = 3.3 x 10(-6)). Both associations remained significant after adjusting for admixture (P = 0.0008 and P = 8.1 x 10(-6), respectively). Similar trends were observed in the independent study group, and the combined analysis of both populations showed a highly significant association of the R230C variant with type 2 diabetes, particularly with that of early onset (P = 7.6 x 10(-6) and 9.4 x 10(-8), respectively). CONCLUSIONS: The R230C ABCA1 variant is associated with type 2 diabetes, particularly of early onset, in the Mexican-Mestizo population.
OBJECTIVE: The ATP-binding cassette transporter A1 (ABCA1) R230C variant is associated with low HDL cholesterol levels, obesity, and the metabolic syndrome in Mexican-Mestizos. Because a pivotal role for ABCA1 in pancreatic beta-cell function was recently observed in the mouse model, we assessed the association of this variant with type 2 diabetes in this population. RESEARCH DESIGN AND METHODS: The initial group included 446 unrelated Mexican individuals: 244 with type 2 diabetes aged 20-69 years (121 with onset </=45 years), and 202 nondiabetic control subjects aged >50 years. An independent study group included 242 type 2 diabetic case subjects and 225 control subjects with similar characteristics. RESULTS: R230C/C230C genotypes were significantly more frequent in type 2 diabetic individuals (24.6%) than in control subjects (11.4%) in the initial study group (OR 2.501; P = 0.001). After stratifying by age at diagnosis, the association was significant only in the early-onset group (age at diagnosis </=45 years) (OR 3.776, P = 3.3 x 10(-6)). Both associations remained significant after adjusting for admixture (P = 0.0008 and P = 8.1 x 10(-6), respectively). Similar trends were observed in the independent study group, and the combined analysis of both populations showed a highly significant association of the R230C variant with type 2 diabetes, particularly with that of early onset (P = 7.6 x 10(-6) and 9.4 x 10(-8), respectively). CONCLUSIONS: The R230C ABCA1 variant is associated with type 2 diabetes, particularly of early onset, in the Mexican-Mestizo population.
Authors: Brian G Drew; Kerry-Anne Rye; Stephen J Duffy; Philip Barter; Bronwyn A Kingwell Journal: Nat Rev Endocrinol Date: 2012-01-24 Impact factor: 43.330
Authors: M A Granados-Silvestre; M G Ortiz-López; J Granados; S Canizales-Quinteros; Rosenda I Peñaloza-Espinosa; C Lechuga; V Acuña-Alonzo; K Sánchez-Pozos; M Menjivar Journal: Mol Genet Genomics Date: 2017-07-07 Impact factor: 3.291
Authors: Andrés Moreno-Estrada; Christopher R Gignoux; Juan Carlos Fernández-López; Fouad Zakharia; Martin Sikora; Alejandra V Contreras; Victor Acuña-Alonzo; Karla Sandoval; Celeste Eng; Sandra Romero-Hidalgo; Patricia Ortiz-Tello; Victoria Robles; Eimear E Kenny; Ismael Nuño-Arana; Rodrigo Barquera-Lozano; Gastón Macín-Pérez; Julio Granados-Arriola; Scott Huntsman; Joshua M Galanter; Marc Via; Jean G Ford; Rocío Chapela; William Rodriguez-Cintron; Jose R Rodríguez-Santana; Isabelle Romieu; Juan José Sienra-Monge; Blanca del Rio Navarro; Stephanie J London; Andrés Ruiz-Linares; Rodrigo Garcia-Herrera; Karol Estrada; Alfredo Hidalgo-Miranda; Gerardo Jimenez-Sanchez; Alessandra Carnevale; Xavier Soberón; Samuel Canizales-Quinteros; Héctor Rangel-Villalobos; Irma Silva-Zolezzi; Esteban Gonzalez Burchard; Carlos D Bustamante Journal: Science Date: 2014-06-12 Impact factor: 47.728
Authors: Chia-Chi C Key; Mingxia Liu; C Lisa Kurtz; Soonkyu Chung; Elena Boudyguina; Timothy A Dinh; Alexander Bashore; Peter E Phelan; Barry I Freedman; Timothy F Osborne; Xuewei Zhu; Lijun Ma; Praveen Sethupathy; Sudha B Biddinger; John S Parks Journal: Cell Rep Date: 2017-06-06 Impact factor: 9.423
Authors: J K Kruit; P H C Kremer; L Dai; R Tang; P Ruddle; W de Haan; L R Brunham; C B Verchere; M R Hayden Journal: Diabetologia Date: 2010-03-13 Impact factor: 10.122
Authors: Xuewei Zhu; Soonkyu Chung; Xin Bi; Chia-Chi Chuang; Amanda L Brown; Mingxia Liu; Jeongmin Seo; Helen Cuffe; Abraham K Gebre; Elena Boudyguina; John S Parks Journal: J Lipid Res Date: 2013-07-27 Impact factor: 5.922